| Date | Time | Source | Announcement |
|---|---|---|---|
| 04 Mar 2022 | 09:42 AM | PDMR Dealing | |
| 03 Mar 2022 | 09:58 AM | PDMR Dealing | |
| 01 Mar 2022 | 04:16 PM | PUBLICATION OF 2021 ANNUAL REPORT | |
| 25 Feb 2022 | 07:00 AM | US launch of EpiSwitch® CiRT for oncology | |
| 15 Feb 2022 | 10:17 AM | PDMR Dealing | |
| 10 Feb 2022 | 11:52 AM | PDMR Dealing | |
| 08 Feb 2022 | 03:10 PM | Holding(s) in Company | |
| 07 Feb 2022 | 02:47 PM | PDMR Dealing | |
| 26 Jan 2022 | 09:50 AM | PDMR Dealing | |
| 25 Jan 2022 | 11:44 AM | PDMR Dealing | |
| 25 Jan 2022 | 07:00 AM | Final Results | |
| 19 Jan 2022 | 09:58 AM | Holding(s) in Company | |
| 14 Jan 2022 | 02:36 PM | Holding(s) in Company | |
| 14 Jan 2022 | 07:00 AM | Holding(s) in Company | |
| 13 Jan 2022 | 12:00 PM | Holding(s) in Company | |
| 11 Jan 2022 | 09:00 AM | Holding(s) in Company | |
| 10 Jan 2022 | 07:02 AM | Holding(s) in Company | |
| 04 Jan 2022 | 07:00 AM | Holding(s) in Company | |
| 29 Dec 2021 | 04:00 PM | Holding(s) in Company | |
| 24 Dec 2021 | 11:40 AM | PDMR Dealing | |
| 23 Dec 2021 | 07:00 AM | Notice of Results | |
| 17 Dec 2021 | 07:00 AM | OBD updates on EpiSwitch CST and CiRT tests | |
| 13 Dec 2021 | 02:23 PM | Holding(s) in Company | |
| 13 Dec 2021 | 10:12 AM | PDMR Dealing | |
| 01 Dec 2021 | 12:00 PM | PDMR Dealing | |
| 24 Nov 2021 | 03:02 PM | PDMR Dealing | |
| 22 Nov 2021 | 11:00 AM | PDMR Dealing | |
| 18 Nov 2021 | 03:16 PM | Holding(s) in Company | |
| 18 Nov 2021 | 03:10 PM | PDMR Dealing | |
| 18 Nov 2021 | 11:53 AM | Holding(s) in Company | |
| 11 Nov 2021 | 11:08 AM | Results of General Meeting | |
| 04 Nov 2021 | 07:00 AM | Holding(s) in Company | |
| 02 Nov 2021 | 12:22 PM | Holding(s) in Company | |
| 01 Nov 2021 | 12:43 PM | Total Voting Rights | |
| 01 Nov 2021 | 07:00 AM | Holding(s) in Company | |
| 25 Oct 2021 | 02:45 PM | OBD raises £3.62 million | |
| 06 Oct 2021 | 04:41 PM | Second Price Monitoring Extn | |
| 06 Oct 2021 | 04:35 PM | Price Monitoring Extension | |
| 28 Sep 2021 | 07:00 AM | Change of Registered Office | |
| 31 Aug 2021 | 07:00 AM | Oxford BioDynamics awarded US FNIH Grant | |
| 15 Jun 2021 | 01:06 PM | PDMR Dealing | |
| 15 Jun 2021 | 07:00 AM | Half-year Report | |
| 27 May 2021 | 09:00 AM | Notice of Results | |
| 14 May 2021 | 10:17 AM | PDMR Dealing / Grant of Share Options | |
| 28 Apr 2021 | 02:24 PM | Holding(s) in Company | |
| 09 Apr 2021 | 07:00 AM | New UK facilities to support expanded strategy | |
| 31 Mar 2021 | 07:00 AM | OBD signs agreement with Agilent Technologies | |
| 24 Mar 2021 | 12:46 PM | Result of AGM | |
| 23 Mar 2021 | 07:00 AM | US launch of EpiSwitch® COVID-19 Severity Test | |
| 17 Mar 2021 | 09:53 AM | Results published of biomarker discovery program |
Oxford Biodynamics' international store for clinical smart tests and research kits based on pioneering EpiSwitch® 3D genomic technology.
OBD was spun out of Oxford University in 2007 to commercialize blood tests based on 3D Genomics research. OBD's tests are designed to help people make informed health decisions and reduce healthcare costs.
OBD share price launched at 162p in 2016.